10x Genomics (TXG)

Last Closing Price: 11.73 (2025-06-27)

Gross Profit (Annual)

Gross Profit: Revenues from operations less the associated costs.

10x Genomics (TXG) had Gross Profit of $414.48M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$610.78M
$-182.63M
$196.30M
Gross Profit
$414.48M
$805.34M
$-194.56M
$16.86M
$-177.70M
$-177.70M
$-182.63M
$-182.63M
$-182.63M
$-182.63M
$-194.56M
$-150.85M
120.45M
120.45M
$-1.52
$-1.52
Balance Sheet Financials
$584.39M
$252.65M
$334.25M
$918.64M
$117.63M
--
$90.87M
$208.50M
$710.13M
$689.95M
$710.13M
122.29M
Cash Flow Statement Financials
$6.66M
$-32.63M
$10.91M
$359.28M
$344.07M
$-15.22M
$140.75M
--
--
Fundamental Metrics & Ratios
4.97
--
--
--
--
67.86%
-31.85%
-31.85%
-24.70%
-29.09%
-29.90%
$-5.73M
--
--
--
0.66
2.36
6.95
52.51
-25.72%
-26.47%
-19.88%
-25.72%
$5.81
$-0.05
$0.06